Ultragenyx Pharmaceutical
RARE
#3225
Rank
C$4.76 B
Marketcap
$50.78
Share price
3.10%
Change (1 day)
-15.77%
Change (1 year)

Earnings for Ultragenyx Pharmaceutical (RARE)

Earnings in 2024 (TTM): -C$0.7 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's current earnings are C$0.56 Billion. , an increase over its 2023 earnings that were of -C$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ultragenyx Pharmaceutical from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.7 Billion-6.99%
2023 -C$0.75 Billion-17.65%
2022 -C$0.91 Billion55.52%
2021 -C$0.59 Billion178.53%
2020 -C$0.21 Billion-59.64%
2019 -C$0.52 Billion1.46%
2018 -C$0.52 Billion12.9%
2017 -C$0.46 Billion32.63%
2016 -C$0.35 Billion67.87%
2015 -C$0.21 Billion160.2%
2014 -C$78.36 Million66.64%
2013 -C$47.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$0.74 B-207.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$39.69 Million-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.35 M-101.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.28 Billion-60.28%๐Ÿ‡บ๐Ÿ‡ธ USA